부산대학교 도서관

Bancos, Anamaria; Ivancuta, Andrei; Moisoiu, Vlad; Tigu, Adrian-Bogdan; Gulei, Diana; Nistor, Madalina; Moldovan, Cristian-Silviu; Kegyes, David; Cenariu, Diana; Zdrenghea, Mihnea; Bojan, Anca; Iancu, Stefania D.; Leopold, Nicolae; Ghiaur, Gabriel; Bumbea, Horia; Tanase, Alina; Einsele, Hermann; Ciurea, Stefan O.; Tomuleasa, Ciprian

Biomarker Research. November 28, 2025, Vol. 13 Issue 1

Drula, R.; Santa, M.; Dirzu, N.; Pasca, S.; Zimta, A.; Tigu, B.; Cenariu, D.; Gulei, D.; Dima, D.; Tomuleasa, C.

Research and Practice in Thrombosis and Haemostasis. 7

Obesity, Fitness & Wellness Week. October 19, 2019, p2510.

Obesity, Fitness & Wellness Week. March 3, 2018, p742

Moisoiu V; Stefancu A; Gulei D; Boitor R; Magdo L; Raduly L; Pasca S; Kubelac P; Mehterov N; Chiș V; Simon M; Muresan M; Irimie AI; Baciut M; Stiufiuc R; Pavel IE; Achimas-Cadariu P; Ionescu C; Lazar V; Sarafian V; Notingher I; Leopold N; Berindan-Neagoe I

International Journal of Nanomedicine, Vol 14, Pp 6165-6178 (2019)

林俊辉; 王建军; 林和山; 何雪宝; 黄雅琴; 李荣冠; 郑凤武; 郑成兴; LIN Junhui; WANG Jianjun; LIN Heshan; HE Xuebao; HUANG Yaqin; LI Rongguan; ZHENG Fengwu; ZHENG Chengxing

渔业科学进展 / Progress In Fishery Sciences. 36(2):23-29

Gulei D.; Raduly L.; Broseghini E.; Ferracin M.; Berindan-Neagoe I.

Molecular Aspects of Medicine. 70:33-56

Muresan, M.S.; Ionescu, C.; Crisan, N.; Andras, I.; Crisan, D.; Vainak, N.; Raduca, E.; Gulei, D.; Berindan-Neagoe, I.

European Journal of Surgical Oncology. 45(2):e92-e92

Gulei, D.; Mehterov, N.; Ling, H.; STANTA, GIORGIO; Braicu, C.; Berindan Neagoe, I.

Biochimica et Biophysica Acta (BBA) - General Subjects. 1861:1661-1675

Chira, S; Gulei, D; Hajitou, A; Berindan-Neagoe, I

Trends in Biotechnology. 36:653-660

Kegyes, D.; Gulei, D.; Drula, R.; Cenariu, D.; Tigu, B.; Dima, D.; Tanase, A.; Badelita, S.; Buzoianu, A.-D.; Ciurea, S.; Ghiaur, G.; Terpos, E.; Ciechanover, A.; Einsele, H.; Tomuleasa, C.

Blood Reviews. 61:101100

Chira, S; Gulei, D; Hajitou, A; Zimta, A-A; Cordelier, P; Berindan-Neagoe, I

Mol Ther Nucleic Acids
Molecular Therapy: Nucleic Acids, Vol 7, Iss C, Pp 211-222 (2017)

Kegyes D; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Bancos A; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tigu AB; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Rus I; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Dima D; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Cenariu D; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Nistor M; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Munteanu R; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Gulei D; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Tanase A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.; Colita A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.; Buzoianu A; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Iuga C; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Zdrenghea M; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece.; Ciurea SO; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Irvine, CA, USA.; Ciechanover A; Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel.; Einsele H; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania.; Department of Internal Medicine II, Julius Maximilians University, Wurzburg, Germany.; Tomuleasa C; Department of Translational Medicine, Medfuture Institute of Medical Research and Life Sciences, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.

Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE

Kegyes D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tat A; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Vizitiu AS; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Vazar-Tripon D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Ilie R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tigu AB; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Cenariu D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Bancos A; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Oncology, Bistrita Emergency Hospital, Bistrita, Romania.; Iluta S; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Oncology, Bistrita Emergency Hospital, Bistrita, Romania.; Jitaru C; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania.; Nistor M; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tomai R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania.; Gulei D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Zdrenghea M; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania.; Einsele H; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Internal Medicine II, Julius Maximilians University, Wurzburg, Germany.; Ghiaur G; Department of Leukemia, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, USA.; Croce CM; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. Carlo.Croce@osumc.edu.; Tomuleasa C; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.; Department of Hematology, Ion Chiricuta Cancer Center, Cluj Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.

Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Tomai R; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; De Las Rivas J; Bioinformatics and Functional Genomics Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Consejo Superior de Investigaciones Cientificas (CSIC) & University of Salamanca (USAL), Salamanca, Spain.; Fetica B; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Bergantim R; Hematology Department, University Hospital Sao Joao Porto São João (ULS), Porto, Portugal.; i3S Instituto de Investigação e Inovação em Saúde University of Porto, Porto, Portugal.; Cancer Drug Resistance Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.; Clinical Hematology Department, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.; Filipic B; Department of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.; Gagic Z; Department of Pharmaceutical Chemistry, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.; Nikolic K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.; Gulei D; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Kegyes D; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Nistor M; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Muresan XM; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Cenariu D; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Feder R; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Pavel-Tanasa M; Department of Immunology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.; Cianga A; Department of Immunology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.; Tigu AB; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Munteanu R; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tanase A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania.; Einsele H; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Julius Maximilians University of Würzburg, Würzburg, Germany.; Tomuleasa C; Department of Hematology - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Personalized Medicine and Rare Diseases - Medfuture Institute for Biomedical Research, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Munteanu R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Gulei D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Moldovan CS; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Department of Nanosciences, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Azzoni E; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Belver L; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Spain.; Catalan Institute of Oncology, Cancer Therapeutic Resistance Program (ProCURE), Badalona, Barcelona, Spain.; Feder R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Pirv S; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Buzoianu AD; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Einsele H; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Mittelman M; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Ghiaur G; Department of Leukemia, Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Hasserjian R; Department of Pathology, Massachusetts General Hospital-Harvard Medical School, Boston, MA, USA.; Tomuleasa C; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ciprian.tomuleasa@umfcluj.ro.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Bancos, A.; Moisoiu, V.; Buran, C.; Cenariu, D.; Nistor, M.; Kegyes, D.; Gulei, D.; Tomuleasa, C.; Iancu, S.D.; Ion, G.; Leopold, N.; Ghiaur, A.; Stancioaica, C.; Ionescu, B.; Dragomir, M.; Coriu, D.; Tigu, A.B.; Buldus, C.F.

In: Journal of Cellular and Molecular Medicine. (Journal of Cellular and Molecular Medicine, March 2025, 29(5))

Tigu AB; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Ivancuta A; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Uhl A; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Sabo AC; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Nistor M; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Mureșan XM; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Cenariu D; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Timis T; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Diculescu D; 2nd Department of Obstetrics and Gynecology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.; Gulei D; Department of Personalized Medicine and Rare Diseases, MEDFUTURE-Institute for Biomedical Research, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

Yunlong Xia; Junmei Shi; Cheng Xun; Bo Kong; Changlin Chen; Yi Zhu; Dengyou Xia

Fire, Vol 8, Iss 9, p 353 (2025)

Tigu AB; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Nistor M; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Gulei D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Constantinescu CS; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania.; Kegyes D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Cenariu D; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Muresan X; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Munteanu R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Feder R; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Jitaru C; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Bancos A; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Santa M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Tomai R; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Damian M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Ivancuta A; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Rus I; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Bojan A; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Zdrenghea M; Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.; Buzoianu AD; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Tanase A; Department of Stem Cell Transplantation, Fundeni Clinical Institute, Bucharest, Romania; Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Einsele H; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Medizinische Klinik Und Poliklinik II, Universitäts klinikum Würzburg, Würzburg, Germany.; Kobold S; Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU Munich, Germany; German Center for Lung Research (DZL), partner site Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health Neuherberg, Germany.; Tomuleasa C; Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Anesthesia and Intensive Care, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Intensive Care Unit, Emergency Clinical Hospital, Cluj-Napoca, Romania. Electronic address: ciprian.tomuleasa@umfcluj.ro.

Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE